EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
    1.17.1.4 | adenine phosphoribosyltransferase deficiency |
18039602 |
[2,8-dihydroxyadenine nephrolithiasis: from diagnosis to therapy] |
causal interaction
diagnostic usage
unassigned |
4
3
0 |
| 1.17.1.4 | Amyotrophic Lateral Sclerosis |
7570184 |
Analysis of aldehyde oxidase and xanthine dehydrogenase/oxidase as possible candidate genes for autosomal recessive familial amyotrophic lateral sclerosis. |
ongoing research
unassigned |
1
0 |
| 1.17.1.4 | Bacterial Infections |
10506947 |
Enzymes involved in purine metabolism--a review of histochemical localization and functional implications. |
causal interaction
unassigned |
3
0 |
| 1.17.1.4 | Carcinoma, Hepatocellular |
3460692 |
Decreased concentration of xanthine dehydrogenase (EC 1.1.1.204) in rat hepatomas. |
causal interaction
diagnostic usage
ongoing research
therapeutic application |
4
2
1
1 |
| 1.17.1.4 | Chagas Disease |
3052441 |
Inhibition of xanthine dehydrogenase from Triatoma infestans by some purine analogues. |
diagnostic usage
unassigned |
2
0 |
| 1.17.1.4 | d-xylulose reductase deficiency |
17872919 |
The RNAi-Mediated Silencing of Xanthine Dehydrogenase Impairs Growth and Fertility and Accelerates Leaf Senescence in Transgenic Arabidopsis Plants. |
ongoing research
unassigned |
2
0 |
| 1.17.1.4 | Lung Injury |
7622587 |
Effect of hypoxia and reoxygenation on the formation and release of reactive oxygen species by porcine pulmonary artery endothelial cells. |
causal interaction
unassigned |
4
0 |
| 1.17.1.4 | Lung Injury |
9655743 |
Upregulation of xanthine oxidase by lipopolysaccharide, interleukin-1, and hypoxia. Role in acute lung injury. |
diagnostic usage
ongoing research
unassigned |
4
2
0 |
| 1.17.1.4 | Neoplasms |
1567224 |
Responses of vascular endothelial oxidant metabolism to lipopolysaccharide and tumor necrosis factor-alpha. |
ongoing research
unassigned |
3
0 |
| 1.17.1.4 | Neoplasms |
18794327 |
Dissecting the role of multiple reductases in bioactivation and cytotoxicity of the antitumor agent 2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone (RH1). |
ongoing research
unassigned |
3
0 |
